Setting 
My Cart
Toggle Nav
mobile icon
Close
  • Menu
  • Setting

Signaling Pathways

Items 491-500 of 6864

Page
per page
  1. Ursodiol
    B2135 Ursodiol
    Summary: Bile acids for PBC treatment
      insoluble in H2O; ≥16 mg/mL
  2. L-DOPA methyl ester (hydrochloride)
    C3785 L-DOPA methyl ester (hydrochloride)
    Summary: dopamine D1 receptor agonist
  3. Loteprednol etabonate
    B2106 Loteprednol etabonate
    Summary: potent glucocorticoid receptor agonist
      insoluble in H2O; insoluble in EtOH; ≥16.95 mg/mL
  4. 4-Quinolinecarboxylic acid
    C6980 4-Quinolinecarboxylic acid
      ≥32.4 mg/mL
  5. 4F 4PP oxalate
    B6334 4F 4PP oxalate
    Summary: 5-HT2A antagonist
      Soluble to 100 mM in DMSO and to 20 mM in ethanol
  6. MM 77 dihydrochloride
    B6511 MM 77 dihydrochloride
    Summary: 5-HT1A receptor antagonist
      <31.38 mg/mL
  7. Xamoterol hemifumarate
    B6519 Xamoterol hemifumarate
    Summary: β1-adrenoceptor partial agonist
      insoluble in DMSO; insoluble in EtOH; ≥25.9 mg/mL
  8. Z-Cyclopentyl-AP4
    B7330 Z-Cyclopentyl-AP4
    Summary: Group III mGlu receptor agonist
  9. Chlorprothixene (hydrochloride)
    C3509 Chlorprothixene (hydrochloride)
    Summary: dopamine D2 receptor antagonist and GABAA receptor inhibitor
      ≥16.75 mg/mL
  10. Itraconazole
    B2104 Itraconazole
     3 Citation
    Summary: antifungal agent
      insoluble in EtOH; insoluble in H2O; ≥8.83 mg/mL

Items 491-500 of 6864

Page
per page